Welcome to our dedicated page for Doximity SEC filings (Ticker: DOCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Doximity, Inc. (DOCS) SEC filings page provides access to the company’s official regulatory disclosures as a New York Stock Exchange–listed issuer. Doximity files annual, quarterly, and current reports that describe its financial condition, results of operations, governance matters, and material events affecting the business.
In its filings and related press releases, Doximity presents condensed consolidated balance sheets, statements of operations, and statements of cash flows, along with discussions of non-GAAP financial measures. The company explains how it calculates metrics such as non-GAAP gross profit, non-GAAP net income, adjusted EBITDA, and free cash flow, and provides reconciliations to GAAP results. These documents allow readers to see how Doximity evaluates its performance beyond standard accounting measures.
Current reports on Form 8-K for DOCS include items such as quarterly earnings announcements, changes in executive roles, annual meeting voting results, and legal developments. For example, Doximity has filed 8-Ks to furnish earnings press releases, to report the outcomes of its annual meeting of stockholders, to disclose changes in its general counsel and related roles, and to describe a securities litigation settlement agreement that remains subject to court approval and other customary conditions.
Through its proxy materials and related filings, Doximity also reports on corporate governance topics, including the election of directors, ratification of its independent registered public accounting firm, and advisory votes on executive compensation. Voting results, including the participation of Class A and Class B common stock, are detailed in these documents.
On this page, AI-powered tools can summarize lengthy DOCS filings, highlight key sections on revenue trends, profitability, cash flows, and risk disclosures, and surface notable items such as settlement agreements or executive transitions. Users can quickly review quarterly reports, annual reports, and Form 4 and other transaction-related filings, while relying on real-time updates from the SEC’s EDGAR system to follow new disclosures from Doximity, Inc.
Doximity, Inc. reporting person Anna Bryson, Chief Financial Officer, had 5,120 shares of Class A common stock withheld on 08/15/2025 to satisfy tax withholding related to the vesting of previously granted restricted stock units. The shares were withheld at a price of $63.54 per share and do not represent a discretionary sale by the reporting person; they were withheld pursuant to an election previously made by the issuer. After the withholding, the reporting person beneficially owns 346,925 shares of Class A common stock.
Jeffrey Tangney, Chief Executive Officer, Director and >10% owner of Doximity, Inc. (DOCS), reported a non‑discretionary reduction of 7,990 shares of Class A Common Stock on 08/15/2025. The shares were withheld by the issuer at a price of $63.54 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. This withholding was made pursuant to an issuer election and is not a voluntary sale by the reporting person. After the withholding, Mr. Tangney beneficially owned 2,249,058 shares of Class A Common Stock according to the Form 4 filing.
Doximity, Inc. (DOCS) Form 144 notifies the market that a person plans to sell 20,000 shares of Common stock through Morgan Stanley Smith Barney LLC on 08/15/2025. The filing lists an aggregate market value of $1,275,566.00 and reports 187,299,459 shares outstanding. The shares to be sold were acquired the same day, 08/15/2025, by stock option exercise from the issuer and paid for in cash. The filer also reported two recent sales in the past three months: 10,000 shares sold on 06/25/2025 for $600,000.00 and 10,000 shares sold on 05/23/2025 for $505,796.00. The signer certifies no undisclosed material adverse information.
Doximity, Inc. announced that its General Counsel, Corporate Secretary, and Chief Compliance Officer, Jennifer Chaloemtiarana, will step down from all three roles effective August 29, 2025, and John Vaughan will assume these positions on the same date.
Chaloemtiarana will continue with the company in an advisory capacity through November 17, 2025, after which she will receive post-employment payments and benefits under her August 10, 2020 offer letter referenced in a prior Form 10-Q filing.
Benjamin Regina M., a director of Doximity, Inc. (DOCS), reported transactions dated 08/08/2025. The Form 4 shows the conversion of 5,000 shares of Class B Common Stock into Class A Common Stock and the sale of 5,000 shares of Class A Common Stock at $63 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted February 26, 2025.
Following the reported transactions the form lists the Reporting Person's beneficial ownership as 16,618 shares of Class A Common Stock. The filing also discloses derivative/option positions, with one line showing 361,138 derivative-equivalent shares beneficially owned after the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/11/2025.
Form 144 filed for proposed sale of common stock. The notice reports a proposed sale of 5,000 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $315,000 and states total shares outstanding of 187,299,459. The securities are shown as acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash.
The filing also discloses prior sales by the same account in the past three months: 5,000 shares sold on 07/11/2025 for $300,200 and 10,000 shares sold on 06/25/2025 for $600,000. The signer attests they have no undisclosed material information as of the notice.